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Elsevier Taiwan LLC. Open access under CSummary Background: Nonpolypoid colorectal neoplasm has been widely recognized in the
past few years. Among nonpolypoid colorectal neoplasms, laterally spreading tumor (LST) is a
unique and distinct category in that the tumor grows horizontally with a size >1 cm. It may be
easily overlooked during colonoscopy. If the size of the colorectal LST is >2 cm, achieving def-
inite management is also another concerning issue. The aim of this study was to improve our
understanding of LST by reviewing its clinical manifestations.
Methods: All the large colorectal LSTs that were diagnosed and managed at our hospital in the
past 2 years were reviewed. Basic demographic datawere recorded. LSTswere divided into gran-
ular (G) and nongranular types (NG), then further subdivided into nodular mixed and homoge-
neous types for the G group and flat elevated and pseudodepressed types for the NG group.
Results: A total of 28 LST in 28 patients were enrolled, with males being more predominant than
females (male/female: 18/10). Mean age of the patients and mean size of the LST were
62.6  9.75 years and 3.4  1.257 cm, respectively. Concerning morphology, 14 were diagnosed
as NG and 14 as G group. The rate of malignant change was 28.6% (8/28). Twenty-three of our
patients received endoscopic treatment (5 for endoscopic piecemeal mucosal resection 18 for
endoscopic submucosal dissection) and five for laparoscopy-assisted colectomy. The cost and
length of admission analysis between the endoscopic and operation treatment groups showed
significant cost reduction (endoscopy/operation: NTD 28172/82516, p< 0.001) and fewer admis-
sion days in the endoscopy therapy group (4.74/9.00, days, p< 0.001). Subgroup comparison be-
tween the G and NG groups did not reveal statistical significance in age, sex ratio, tumor size,
rate of malignant change, or location.
Conclusion: Although long-term outcome comparison was lacking, endoscopic treatment should
be considered firstly for colorectal LSTunder the consideration of shorter hospitalization. Most ofastroenterology, Department of Internal Medicine, Yuan’s General Hospital, Number 162 Cheng-Gong
om (W.-H. Hsu).
3.09.001
stroenterological Society of Taiwan and The Digestive Endoscopy Society of Taiwan. Published by
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pseudodepressed subtypes in nongrour analyses between the G and NG groups were statistically insignificant, which is likely to be
due to the small population base.
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Nonpolypoid colorectal neoplasms have been well reported
and gradually acknowledged in countries outside Japan.
The laterally spreading tumor (LST), defined as a lesion
with horizontal growth over 1 cm and relatively limited
vertical growth, is a unique endoscopic morphology among
nonpolypoid colorectal neoplasms [1]. It also tends to be
different from other colorectal neoplasms in genetics
analysis [2,3]. There are two morphology classifications for
colorectal LST: granular (G) type and nongranular (NG)
type. These groups can be further subclassified into ho-
mogeneous (HM) and nodular mixed (NM) types for LST-G
and flat-elevated (FE) and pseudodepressed (PD) types for
LST-NG [1]. These different subclassifications have their
own clinicopathological manifestations and may need
different treatment strategies. For sizes <2 cm, endoscopic
resection should be the mainstay treatment. If the size of
LST in the colorectum is >2 cm, endoscopic resection be-
comes more difficult and challenging. An operation would
be suggested for lesions with a larger size, although endo-
scopic mucosal resection (EMR) and a newly developed
technique, endoscopic submucosal dissection (ESD), have
become gradually utilized for large LST resection [4e8].
The clinical manifestations and management have seldom
been reported in Taiwan. Here, we reviewed our colorectalB) nodular mixed subtypes of
anular laterally spreading tumoLST cases with a size over 2 cm during the past 2 years and
analyzed the cost and days of hospitalization between
operation and endoscopic management.
Methods
We reviewed our endoscopic electronic report system from
July 2010 to August 2012. LSTs with size over 2 cm were
selected. Demographic data about age, sex, polyp location
and size were identified. All the LST were subgrouped as G
and NG types according to the endoscopic morphology. The
G group was subclassified into: HM type (Fig. 1A) if the
granular pattern was uniform; and NM type (Fig. 1B) if a big
nodular lesion was noted. The NG group was subclassified
into: FE type (Fig. 1C) if the lesion was flat and evenly
raised; and PD type (Fig. 1D) if a slight central depression
was detected. If an initial endoscopic morphology was not
given, the endoscopic pictures were reviewed and classified
according to the above definition. According to the man-
agement, patients were further divided into operation and
endoscopic groups. EMR, endoscopic piecemeal mucosal
resection (EPMR), and ESD were endoscopic methods used
in the endoscopic management group. We began to perform
colorectal ESD in July 2010. During the early stages, we
fully explained the risks and benefits of each management
to patients when a lesion over 2 cm in size was identified.granular laterally spreading tumors; (C) flat-elevated and (D)
rs.
Table 1 Patient information and demographic data.
Total
Male ratio, % 64.3 (18/28)
Age, mean (SD) 62.6 (9.75)
Lesion size, cm (SD) 3.4 (1.257)
Morphology, granular ratio, % 50 (14/28)
Subclassification, HM/NM/FE/PD 7/7/13/1
Rate of malignancy, % 28.6 (8/28)
Endoscopic management, % 82.1 (23/28)
Proximal location, % 57.4 (16/28)
FEZ flat elevated; HMZ homogeneous; NMZ nodular mixed;
PD Z pseudodepressed; SD Z standard deviation.
40 W.-H. Hsu et al.Some patients, therefore, chose an operation as manage-
ment for their colorectal LST. As our ESD technique im-
proves, it has gradually become the first treatment choice
for en-bloc resection. If the pathology disclosed intra-
mucosal carcinoma or T1 above, the tumor was regarded as
malignant. Because some of our patients diagnosed as
colorectal LST were admitted initially for other purposes,
days of hospitalization were calculated from the day prior
to endoscopic therapy to the day patients were discharged.
We reviewed patients’ medical costs according to the cost
reported to the National Health Insurance system (NHI),
regardless of the fees paid by patients themselves. Due to
the hospital policy, patients treated as ESD were not
charged extra fees.
Statistical analysis
Variable comparison between the G and NG groups was
analyzed by Chi-square test. Two-sample t test was utilized
to analyze cost and length of hospitalization between pa-
tients who received endoscopic and surgical management.
Statistical analysis was conducted by PASW Statistics
version 18.0 for Windows (SPSS Inc., Chicago, IL, USA). A p
value <0.05 was defined as the level of statistical
significance.
Results
A total of 28 patients with 28 colorectal LSTs were enrolled
for analysis. Males had a percentage of 64.3% with a
mean  standard deviation age of 62.6  9.75 years. Mean
lesion size was 3.4  1.257 cm with a rate of malignancy ofTable 2 Comparison between granular and non-granular group
Granular
Male ratio, % 78.61 (11/14)
Age, mean (SD) 64.64 (8.785)
Lesion size, cm (SD) 3.71 (1.267)
Rate of malignancy, % 35.7 (5/14)
Subclassification
rate of malignancy
NM/HM: 57.1%/14.3%,
p Z 0.266
Proximal location, % 71.4 (10/14)
FE Z flat elevated; HM Z homogeneous; NM Z nodular mixed; PD Z28.6% (8/28, 2 for T1 cancer, 6 for intramucosal carci-
noma). The numbers of G and NG were equal (G/NG: 14/
14). Regarding the subclassification, the numbers for HM,
NM, FE, and PD were seven, seven, 13, and one, respec-
tively. Twenty-three (82.1%) of our patients chose endo-
scopic resection as their management (Table 1). The en-
bloc resection rate in our ESD group was 83.3% (15/18) with
R0 resection to 77.8% (14/18). A perforation case occurring
in the very early period of our colorectal ESD was referred
for surgical management, and discharged uneventfully. No
delayed bleeding or delayed perforation occurred.
Furthermore, no major comorbidities were noted in any of
our patients. There was no statistical significance between
the G and NG groups in terms of maleefemale ratio, age,
lesion size, lesion location, or malignancy rate (Table 2). In
the subgroup analysis, the NM and PD groups had a trend
with a more malignant change when compared with the HM
and FE groups, respectively, although neither difference
was statistically significant (NM/HM: 57.1%/14.3%,
pZ 0.266; PD/FE: 100%/15.4%, pZ 0.214). The endoscopic
management group had significantly less medical costs
(p < 0.001) and fewer admission days (p < 0.001) than the
operation group (Table 3).
Discussion
Our endoscopic procedures for colorectal LST included
EMR, EPMR, and ESD. As mentioned above, the management
chosen did not fully conform to the Japanese criteria. In
Japan, the choice of EMR or ESD depends on the LST
morphology classification [9]. LST-G and LST-NG may have
different gastrointestinal phenotype and genotype [10,11].
Because of the higher risk of multiple minute invasions, ESD
is recommended for all LST-NG to get en-bloc resection for
thorough pathological examination [9]. If EMR for LST-G
with NM type is performed, the nodular structure should
be removed firstly because it carries a higher risk of ma-
lignant change [9]. According to Japan’s colorectal ESD
standardization implementation working group, ESD is
indicated for lesions over 20 mm and difficult-to-obtain en-
bloc resection by EMR, lesions with fibrosis, sporadic
localized tumors in colon with chronic inflammation, and
local residual early carcinoma after endoscopic resection
[12]. ESD for colorectal tumors has also been approved by
Japan’s public health insurance system since April 2012.
Although the indication of the largest lesion size was
refined at 50 mm, the approval by the insurance system
validated the feasibility of ESD as the first choice for earlys for lesion size, location and rate of malignancy.
Nongranular p
59 (7/14) 0.237
60.5 (10.537) 0.269
3.07 (1.207) 0.181
21.4 (3/14) 0.252
PD/FE: 100%/15.4%,
p Z 0.214
42.9 (6/14) 0.676
pseudodepressed; SD Z standard deviation.
Table 3 Days of hospitalization comparison between
surgical and endoscopic groups.
Surgical,
n Z 5
Endoscopic,
n Z 23
p
Days of
hospitalization
(SD)
9 (2.550) 4.74 (2.320) <0.001
SD Z standard deviation.
Colorectal laterally spreading tumor 41colorectal neoplasms (http://recenavi.net/2012/K/K721-4.
html, accessed January 13, 2013). By contrast, colorectal
ESD is regarded as a difficult technique and should
commence after gaining experience of gastric ESD, good
colonoscopy manipulation, and diagnostic ability [13].
When comparing with EPMR/EMR, colorectal ESD also
carries a longer procedure time and higher complication
rate, although it has a lower local recurrence rate and
higher en-bloc rate [14,15]. The endoscopic treatment for
colorectal LST, regardless of ESD or EMR, should be per-
formed after good training and understanding of these
procedures [16].
The management of endoscopically resected specimen is
important. It should be retracted carefully, stretched well,
and fixed firmly on a plate. Therefore, the good orientation
may make the histological examination more precise. The
specimen should be sliced with a 1e2 mm interval. Once
the malignancy is diagnosed, the occurrence of invasion to
the submucosal layer or the depth of invasion should be
clearly defined. If the layer of muscularis mucosa remains,
the depth of submucosal invasion is measured from the
layer of muscularis mucosa; it should be measured from the
tumor surface if the layer of muscularis mucosa is already
destroyed by cancer cells [17]. These procedures inevitably
increase the workload of the pathology department. The
imbalance between the workload and insurance payment
may hinder the pathologists to adhere to these steps
adequately. Therefore, good communication with the
pathologist and an effort to revise the insurance reim-
bursement are necessary. Any violation against these pro-
cedures may result in under-diagnosis of the lesion. Precise
and accurate pathological examination could select pa-
tients for whom subsequent surgery is necessary to prevent
rapid local recurrence. According to the Japanese guide-
lines, subsequent surgery for lymph node dissection is
considered if any one of the following criteria is met: (1)
depth of submucosal invasion 1000 mm; (2) positive
vascular invasion; (3) poorly differentiated adenocarci-
noma, signet-ring cell carcinoma, or mucinous carcinoma;
or (4) grade 2/3 budding at the site of deepest invasion
[18,19]. Subsequent surgery should be highly recommended
for patients who meet any one of the above criteria as it is
associated with long-term outcome [20].
Our results show that endoscopic resection for colo-
rectal LST has significantly less medical expense and
duration of hospitalization than an operation. However, our
cost analysis for the endoscopic group was based on NHI
costs, regardless of the fee paid by patients themselves.
Endoscopic management, particularly for ESD, is expensive
for its instruments and is still not covered by the NHI sys-
tem. Therefore, the charge for ESD (esophagus, stomach,and colorectum) in Taiwan varies across different hospitals.
Colorectal ESD has been fully included in Japan’s insurance
system since April 2012. It was firstly approved as an
“advanced medical treatment” system, which is a partial-
care service provided by the Japanese public health insur-
ance with individual payment of medical expenses [12].
Since then, the actual medical expenses reported to the
insurance system have increased [21]. EMR for gastroin-
testinal tract polyp over 2 cm, malignant lesion or submu-
cosal tumor has been approved by Taiwan’s NHI system
since 2013. The actual discrepancy of medical expenses
between surgical treatment and EMR would be clearly seen
in the future. Moreover, due to the foreseeable growing
numbers of endoscopic treatment, a large-scale study on
the comparison among surgical management, ESD, and EMR
would be feasible in Taiwan.
Our results fail to show any significant difference of
malignant change rate among each subclassifications,
probably due to our small population. Although not statis-
tically significant, the result of higher malignancy rate in
the NM and PD type groups was similar to other studies
[10,22,23]. To improve our understanding of colorectal LST
in Taiwan, a multicenter study is necessary.
Although an increasing amount of studies, not only from
Japan but also Asian and European countries, have shown
that colorectal ESD could be a safe procedure for colorectal
neoplasms [24,25]. ESD is still regarded as a difficult, time-
consuming, and risky procedure and needs a long learning
curve [26]. A multicenter study conducted by Moss et al [27]
also showed that EMR could be safe and effective for large
sessile colonic polyps. Therefore, the endoscopic choices
between ESD and EMR for colorectal LST should depend on
the characteristics of the lesions, technique of the endo-
scopists, and even on the insurance reimbursement system.
Given the marked reduction in days of hospitalization and
safety, endoscopic treatment for large colorectal LST
should be initially considered for every patient without a
high risk of deep submucosal invasion and/or risk of lymph
node metastasis.
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